MannKind Corporation said last week it picked up ex-Insulet (NSDQ:PODD) CEO Duane DeSisto as its new prez and CEO, effective January 5, 2016. DeSisto will replace interim CEO Alfred Mann, who has held the spot since November. DeSisto will also join the company’s board of directors, according to a press release from the Valencia, Calif.-based company. […]
Nephros
NeuSpera Medical lands ex-Cyberonics R&D SVP Morris for CEO | Personnel Moves
NeuSpera Medical said it snagged the former R&D senior vice president at Cyberonics, Milton Morris, for its corner office as it gears up to raise a Series A round for its neuromodulation technology. NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology. The Santa Clara, […]
HART CEO Green bows out | Personnel Moves
DexCom elevates COO Sayer, Gregg to chairman | Personnel Moves
Nephros expands European distribution deal
Nephros (OTC:NEPH) said it plans to extend and expand its deal with Italian distributor Bellco Srl, adding more countries to their existing deal.
Mirandola-based Bellco is focused on providing dialysis and extracorporeal blood purification technology. The 2 companies have extended their deal until Dec. 31, 2021, according to a press release.
Nephros plummets 68% on filter recall
Report: CMS Innovation Center’s 1st chief on the way out
Dr. Richard Gilfillan, the 1st leader of the recently-created Center for Medicare & Medicaid Services Innovation Center, will hand over the reigns at the end of the month, and no replacement has yet been named.
AtriCure prices $24M stock offering | Wall Street Beat
AtriCure (NSDQ:ATRC) priced a public offering of nearly 3.5 million shares of stock at $7.25 per share, saying it expects net proceeds of about $23.5 million.
The West Chester, Ohio-based medical device company said it granted underwriter Piper Jaffray a 30-day over-allotment option for another 521,000 shares.
FDA clears Ethicon’s 1st surgical set docs can assemble inside the body | Regulatory Roundup
Johnson & Johnson (NYSE:JNJ) Ethicon Endo-Surgery won FDA clearance for the 1st surgical instruments that can be assembled and disassembled inside the body during surgery.